| 國立成功大學 |
2017-08 |
High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia
|
Hu;Yu-Ning;Lee;Nan-Yao;Roan;Jun-Neng;Hsu;Chi-Hsin;Luo;Chwan-Yau |
| 國立成功大學 |
2003-07 |
High-dose chemotherapy and hematopoietic stem cell transplantation for patients with nasopharyngeal cancer: a feasibility study
|
Chen, Tsai-Yun; Chen, HelenH. W.; Su, Wu-Chou; Tsao, Chao-Jung |
| 臺大學術典藏 |
2018-09-10T04:04:31Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen, M.-L. and Chen, Y.-C. and Lin, M.-T. and Liu, M.-C. and Tang, J.-L. and Wang, C.-H. and Hsieh, C.-Y.; MEN-LUH YEN |
| 臺大學術典藏 |
1992 |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
MEN-LUH YEN; Chen Y.-C; Lin M.-T; Liu M.-C; Tang J.-L; Wang C.-H; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-11T01:44:01Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Men-Luh Yen;Chen Y.-C;Lin M.-T;Liu M.-C;Tang J.-L;Wang C.-H;Hsieh C.-Y.; MEN-LUH YEN; Chen Y.-C; Lin M.-T; Liu M.-C; Tang J.-L; Wang C.-H; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:14:57Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen M.-L.;Chen Y.-C.;Lin M.-T.;Liu M.-C.;Tang J.-L.;Wang C.-H.;Chang-Yao Hsieh; Yen M.-L.; Chen Y.-C.; Lin M.-T.; Liu M.-C.; Tang J.-L.; Wang C.-H.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2021-01-06T03:59:08Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen M.-L.; Chen Y.-C.; Lin M.-T.; Liu M.-C.; JIH-LUH TANG; Wang C.-H.; Hsieh C.-Y. |
| 國立臺灣大學 |
1992 |
High-Dose Chemotherapy with Support by Autologous Bone Marrow and GM-CSF in the Treatment of Advanced Ovarian:Preliminary Report of a New Strategy
|
嚴孟祿; Chen, Y. C.; Lin, M. T.; Liu, M. C.; Tang, J. L.; Wang, C. H.; 謝長堯; Yen, Men-Lun; Chen, Y. C.; Lin, M. T.; Liu, M. C.; Tang, J. L.; Wang, C. H.; Hsieh, Chang-Yao |
| 臺大學術典藏 |
2022-04-25T06:12:28Z |
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
|
Chen C.-H;Chou Y.-T;Yang Y.-W;Lo K.-Y.; Chen C.-H; Chou Y.-T; Yang Y.-W; Lo K.-Y.; KAI-YIN LO |
| 臺大學術典藏 |
2022-07-21T06:02:23Z |
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
|
Chen, Chieh-Hsin; Chou, Yi-Ting; YA-WEN YANG; Lo, Kai-Yin |
| 國立臺灣大學 |
2015 |
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
|
Yang, Jyh-Chin; Lin, Chun-Jung; Wang, Hong-Long; Chen, Jin-De; Kao, John Y.; Shun, Chia-Tung; Lu, Chien-Wei; Lin, Bor-Ru; Shieh, Ming-Jium; Chang, Ming-Chu; Chang, Yu-Ting; Wei, Shu-Chen; Lin, Lin-Chih; Yeh, Wen-Chun; Kuo, Jen-Shin; Tung, Chien-Chih; Leong, Yew-Loong; Wang, Teh-Hong; Wong, Jau-Min; 王德宏; 謝銘鈞; 董建志; 楊智欽; 翁昭旼; 章明珠; 魏淑?; 張毓廷; 孫家棟; 林伯儒; 林君榮 |
| 臺大學術典藏 |
2018-09-10T15:26:48Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang, J.-C. and Lin, C.-J. and Wang, H.-L. and Chen, J.-D. and Kao, J.Y. and Shun, C.-T. and Lu, C.-W. and Lin, B.-R. and Shieh, M.-J. and Chang, M.-C. and Chang, Y.-T. and Wei, S.-C. and Lin, L.-C. and Yeh, W.-C. and Kuo, J.-S. and Tung, C.-C. and Leong, Y.-L. and Wang, T.-H. and Wong, J.-M.; Yang, Jyh-Chin;Lin, Chun-Jung;Wang, Hong-Long;Chen, Jin-De;Kao, John Y.;Shun, Chia-Tung;Lu, Chien-Wei;Lin, Bor-Ru;Shieh, Ming-Jium;Chang, Ming-Chu;Chang, Yu-Ting;Wei, Shu-Chen;Lin, Lin-Chih;Yeh, Wen-Chun;Kuo, Jen-Shin;Tung, Chien-Chih;Leong, Yew-Loong;Wang, Teh-Hong;Wong, Jau-Min; 王德宏;謝銘鈞;董建志;楊智欽;翁昭旼;章明珠;魏淑?;張毓廷;孫家棟;林伯儒;林君榮; Hsieh, Yi-Ping; CHUN-JUNG LIN; Yang, Jyh-Chin; YU-TING CHANG; Shen, April Chiung-Tao; Lin, Chun-Jung; Wang, Hong-Long; Wei, Hsi-Sheng; JYH-CHIN YANG; CHIA-TUNG SHUN; Chen, Jin-De; Feng, Jui-Ying; Huang, Soar Ching-Yu; Kao, John Y.; BOR-RU LIN; Hwa, Hsiao-Lin; Shun, Chia-Tung; Lu, Chien-Wei; Lin, Bor-Ru; Shieh, Ming-Jium; Chang, Ming-Chu; Chang, Yu-Ting; Wei, Shu-Chen; Lin, Lin-Chih; Yeh, Wen-Chun; Kuo, Jen-Shin; Tung, Chien-Chih; Leong, Yew-Loong; Wang, Teh-Hong; Wong, Jau-Min; 華筱玲 |
| 臺大學術典藏 |
2020-08-07T01:43:05Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lu C.-W.; Shun C.-T.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Leong Y.-L.; Wang T.-H.; Wong J.-M.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; CHIEN-CHIH TUNG |
| 臺大學術典藏 |
2020-10-14T07:24:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Wang T.-H.; Tung C.-C.; Leong Y.-L.; Kuo J.-S.; Yeh W.-C.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Wong J.-M. |
| 臺大學術典藏 |
2021-02-04T07:16:09Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; YU-TING CHANG; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-05-27T02:50:08Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-04T03:09:10Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Chun-Jung Lin;Wang H.-L.;Chen J.-D.;Kao J.Y.;Shun C.-T.;Lu C.-W.;Lin B.-R.;Shieh M.-J.;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; CHUN-JUNG LIN; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:06Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2022-03-04T08:22:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-02-02T08:29:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; BOR-RU LIN; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-05T06:07:21Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; MING-CHU CHANG; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-18T02:02:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Chia-Tung Shun;Lu C.-W.;Lin B.-R.;Shieh M.-J.;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; CHIA-TUNG SHUN; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2020-02-27T06:39:29Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Shun C.-T.;Lu C.-W.;Lin B.-R.;Ming-Jium Shieh;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; MING-JIUM SHIEH; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 國立臺灣大學 |
2013 |
High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
|
Huang, Bing-Shen; Tsang, Ngan-Ming; Lin, Shi-Ming; Lin, Deng-Yn; Lien, Jau-Min; Lin, Chen-Chun; Chen, Wei-Ting; Chen, Wan-Yu; Hong, Ji-Hong; 陳婉瑜 |
| 臺大學術典藏 |
2020-07-17T03:46:02Z |
High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
|
J.H. Hong; WAN-YU CHEN; W.T. Chen; C.C. Lin; J.M. Lien; D.Y. Lin; S.M. Lin; Huang B.S; N.M. Tsang |
